Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profiling of the whole brain of the Huntington disease model mouse R6/2 at 5 weeks post-natal age using transcriptome tomography

ABSTRACT: We developed a novel framework to assess comprehensive endogenous gene expression maps in a broad and isotropic 3D-anatomical context using a relatively small number of original data points: transcriptome tomography. Using this method, we produced a dataset of gene expression maps of the whole brain of the Huntington disease model mouse R6/2 at 5 weeks after birth, computationally reconstructed from fraction data.

ORGANISM(S): Mus musculus

PROVIDER: GSE227657 | GEO | 2025/12/03

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gene expression profiling of the whole brain of the normal littermate control for Huntington disease model mouse R6/2 at 5 weeks post-natal age using transcriptome tomography

2025-12-03 | GSE227658 | GEO

Gene expression profiling of the whole mouse brain at 3 days post-natal age using transcriptome tomography

2018-08-07 | GSE118176 | GEO

Gene expression profiling of the whole mouse brain at 7 days post-natal age using transcriptome tomography

2018-08-07 | GSE118177 | GEO

Gene expression profiling of the whole mouse brain at 3 weeks of post-natal age using transcriptome tomography

2018-08-07 | GSE118178 | GEO

Gene expression profiling of the whole mouse brain using transcriptome tomography

2012-09-21 | GSE36408 | GEO

Gene expression profiling of the whole mouse brain using transcriptome tomography

Project description:We developed a novel framework to assess comprehensive endogenous gene expression maps in a broad and isotropic 3D-anatomical context using a relatively small number of original data points: transcriptome tomography. Using this method, we produced a dataset of gene expression maps of the whole mouse brain, computationally reconstructed from fraction data. A total of 61 fraction samples obtained with body axes-based slicing preparation conjugated with anatomical image acquisition were analysed. There are two sets of body axes-based preparation series: the S series, composed of 9 fractions/ C of 13 fractions/ H of 6 fractions , and the So series, composed of 10 fractions/ Co of 16 fractions/ Ho of 7 fractions.

2012-09-21 | E-GEOD-36408 | biostudies-arrayexpress

RARb and Huntington Disease

Project description:Our working hypothesis is that two genetic factors A (compromized Rarβ expression in Rarβ+/- mice) and B (mutant form of huntingtin; R6/1 Tg/0) can synergise in generating physiopathology of Huntington disease. To address this point we performed comparative transcritomics in the nucleus accumbens (NAc) for 4 experimental groups : 1) R6/1 Tg/0 ; Rarβ+/-, (n=3); 2) R6/1 Tg/0 ; Rarβ+/+, (n=3); 3) R6/1 0/0 ; Rarβ+/-, (n=3); 4) R6/1 0/0 ; Rarβ+/+ (n=2).

2025-04-29 | GSE270980 | GEO

Gene expression profiling of the whole brain of the Huntington disease model mouse R6/2 at 5 weeks post-natal age using transcriptome tomography

Project description:Gene expression profiling of the whole brain of the Huntington disease model mouse R6/2 at 5 weeks post-natal age using transcriptome tomography

| PRJNA946292 | ENA

Gene expression profiling of the whole brain of the normal littermate control for Huntington disease model mouse R6/2 at 5 weeks post-natal age using transcriptome tomography

Project description:Gene expression profiling of the whole brain of the normal littermate control for Huntington disease model mouse R6/2 at 5 weeks post-natal age using transcriptome tomography

| PRJNA946293 | ENA

Integrative Characterization of the R6/2 Mouse Brain Model of Huntington Disease Reveals Dysfunctional Neurotransmitter Metabolism

Project description:Huntington disease (HD) is a fatal neurodegenerative disease, where dysfunction and loss of striatal and cortical neurons are central to the pathogenesis of the disease. Here, we integrated quantitative studies to investigate the underlying mechanisms behind HD pathology in a systems-wide manner. To this end, we used state-of-the-art mass spectrometry (MS) to establish a spatial brain proteome from late-stage R6/2 mice and compared this to wild-type (WT) counterparts. From the quantitative analysis, we observed altered expression of proteins in pathways related to energy metabolism, synapse function, and neurotransmitter homeostasis. To support these findings, metabolic 13C labelling studies confirmed a compromised astrocytic regulation of glutamate-GABA-glutamine cycling resulting in impaired release of glutamine and GABA synthesis. In recent years increasing attention has been focused on the role of astrocytes in HD, and our data supports that therapeutic strategies to improve astrocytic glutamine metabolism may help ameliorate symptoms in HD.

2019-01-11 | PXD008099 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data